9-(4-chlorophenylsulfonyl)-9-azabicyclo[3.3.1]nonan-3-one oxime | 928055-90-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 9-(4-chlorophenylsulfonyl)-9-azabicyclo[3.3.1]nonan-3-one oxime
• 英文别名: N-[9-(4-chlorophenyl)sulfonyl-9-azabicyclo[3.3.1]nonan-3-ylidene]hydroxylamine
• CAS: 928055-90-7
• 化学式: C₁₄H₁₇ClN₂O₃S
• 分子量: 328.82
• InChiKey: DMVNNTPAAWNJQW-UHFFFAOYSA-N

物化性质

• 沸点：
  513.0±60.0 °C(Predicted)
• 密度：
  1.53±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  21
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  78.4
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  9-[(4-chlorophenyl)sulfonyl]-9-azabicyclo[3.3.1]nonan-3-one 在 羟胺 作用下， 以 乙醇 为溶剂， 生成 9-(4-chlorophenylsulfonyl)-9-azabicyclo[3.3.1]nonan-3-one oxime
  参考文献：
  名称：

  Discovery of sulfonamide–pyrazole γ-secretase inhibitors

  摘要：

  Utilizing a pharmacophore hypothesis, previously described gamma-secretase inhibiting HTS hits were evolved into novel tricyclic sulfonamide-pyrazoles, with high in vitro potency, good brain penetration, low metabolic stability, and high clearance. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2010.02.050

文献信息

• Bridged N-Bicyclic Sulfonamido Inhibitors of Gamma Secretase
  申请人：Konradi Andrei W.

  公开号：US20110178119A1

  公开（公告）日：2011-07-21

  The invention provides N-bicyclic sulfonamido compounds of Formula (I) wherein A is as described in the specification and R 1 and R 2 combine to form a [3.3.1] or a [3.2.1] ring system. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of treating cognitive disorders, such as Alzheimer's disease.

  本发明提供了公式（I）的N-双环磺酰胺化合物，其中A如说明书所述，R1和R2结合形成[3.3.1]或[3.2.1]环系统。公式I的化合物在治疗或预防认知障碍，如阿尔茨海默病方面具有用途。本发明还包括含有公式（I）的药物组合物以及治疗认知障碍，如阿尔茨海默病的方法。
• BRIDGED N-BICYCLIC SULFONAMIDO INHIBITORS OF GAMMA SECRETASE
  申请人：Elan Pharmaceuticals Inc.

  公开号：EP1915371A2

  公开（公告）日：2008-04-30
• [EN] BRIDGED N-BICYCLIC SULFONAMIDO INHIBITORS OF GAMMA SECRETASE<br/>[FR] INHIBITEURS SULFONAMIDO N-BICYCLIQUES PONTES DE GAMMA-SECRETASE
  申请人：ELAN PHARM INC

  公开号：WO2007024651A2

  公开（公告）日：2007-03-01

  [EN] The invention provides N-bicyclic sulfonamido compounds of Formula (I) wherein A is as described in the specification and R₁ and R₂ combine to form a [3.3.1] or a [3.2.1] ring system. Compounds of Formula I are useful in treating or preventing cognitive disorders, such as Alzheimer's Disease. The invention also encompasses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of treating cognitive disorders, such as Alzheimer's disease.
  [FR] L'invention concerne des composés sulfonamido N-bicycliques représentés par la formule (I) dans laquelle A possède la signification donnée dans le descriptif et R₁ et R₂ se combinent de manière à former un système cyclique [3.3.1] ou [3.2.1]. Les composés représentés par la formule (I) servent au traitement ou à la prévention de troubles cognitifs tels que la maladie d'Alzheimer. L'invention concerne également des compositions pharmaceutiques contenant des composés représentés par la formule (I) ainsi que des procédés de traitement de troubles cognitifs tels que la maladie d'Alzheimer.